Principal Investigator Philip J. Stella has won the 2019 Harry Hynes Award. An investigator with the Michigan Cancer Research Consortium NCI Community Oncology Research Program site in Ann Arbor, Stella is being recognized for outstanding contribution to clinical trials and clinical research.
The Cancer Letter includes a write up—follow the source link below. TrialSite News offers a brief review of Dr. Stella’s background.
What is the Harry Hynes Award?
The NCORP’s Harry Hynes award recognizes local community researchers who embody the attributes of the leadership and commitment demonstrated by Harry Hynes, an Irish native who came to Wichita, Kan., in 1960 and went on to be a pioneer in developing one of the nation’s first Clinical Community Oncology Programs in 1983.
Dr Philip J. Stella
Dr. Stella is a physician with IHA Hematology Oncology Consultants, and he is the Medical Director of the Oncology Program at the St. Joseph Mercy Hospital Cancer Center in Ann Arbor, MI. Dr. Stella has clinical interest in lung, gastrointestinal, and breast cancers. He is Principal Investigator of the Michigan Cancer Research Consortium (MCRC) participating in the National Cancer Institute’s (NCI) Community Oncology Research Program. In 2014, NCI funded MCRC with a $10 million award. MCRC was selected as one of 34 community sites across the country to receive the 5-year grant enabling patients throughout the 13-hospital consortium to participate in cutting-edge clinical trials offering access to the top cancer treatments available.